Denver, CO  2/22/2013 (BasicsMedia)  —  Friday’s in February are cold and snowy and 2013 is little different from previous years.  Here are some morning movers to take note of prior to markets opening today.

Boeing (NYSE:BA) is today expected to present a redesign of its 787 batteries to stop them overheating as it looks to persuade the FAA to allow the Dreamliners to resume passenger flights, hopefully next month. CEO Jim McNerney has told the WSJ that Boeing is confident it has identified “all probable causes” of the battery failures.

AIG (NYSE:AIG) swung to a net loss of $4B in Q4 from a profit of $21.5B a year earlier, when it benefited from a tax-related accounting gain of $19.2B. The result this year was due to an after-tax loss of $1.3B because of Superstorm Sandy and a $4.4B loss related to the sale of AIG’s airplane leasing unit. The insurer’s operating EPS dropped to $0.20 from $0.77, although that was better than expectations for a loss. Shares were +3.5% premarket.

ING (NYSE:ING) CEO Jan Hommen will step down in October and be replaced by Ralph Hamers, the head of the Dutch bank’s Belgian operations. Hamers, who joined ING in 1991, has “an excellent track-record…in leading strategic change processes,” ING said. That should come in handy, given the massive changes the bank’s been going through, including selling billions of dollars of assets. Shares were +0.7% premarket.

Frank Kendall, the Under Secretary of Defense for Acquisition, has authorized the Pentagon’s purchasers and program managers to start talking to suppliers about the plans for implementing $46B of automatic cost reductions, which are due to take effect next Friday. The impact of the cuts will be exacerbated by the DOD not receiving an appropriation for this year, with much of its money in the wrong accounts.

Warburg Pincus is reportedly considering an IPO for its Bausch & Lomb eyecare unit after efforts to find a buyer fell flat. Big names such as Abbott Laboratories (NYSE:ABT), Johnson & Johnson (NYSE:JNJ) and Sanofi (NYSE:SNY) showed early interest, but Warburg wasn’t able to secure a bid of at least $9B.

GM (NYSE:GM) intends to invest $7.3B in its South Korean operations over the next five years to improve its manufacturing and engineering capabilities, and double the size of its design center at its HQ in Incheon. The plan runs counter to recent speculation that GM was intending to cut production and jobs in Korea.

Disclaimer: This article is intended for informational and entertainment use only, and should not be construed as professional investment advice. They are my opinions only. Trading stocks is risky — always be sure to know and understand your risk tolerance. You can incur substantial financial losses in any trade or investment. Always do your own due diligence before buying and selling any stock, and/or consult with a licensed financial adviser.

DISCLAIMER: This content is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.